Dendritic cells and their role in cancer immunotherapy

Melnikova A.A. Grivtsova L.Yu.

Journal: Cardiometry @cardiometry

Section: Conference proceedings

Article in issue: 29, 2023.

Free access

Cytotoxic CD8+ T lymphocytes (CD8+ CTLs) are key effector cells, which recognize and kill tumor cells, and are therefore preferred targets for improved cancer immunotherapy.

dendritic cells \ cancer immunotherapy \ dc vaccines \ antitumor t cell response

Similar articles in the section Blood. Cardiovascular, circulatory system

Tumor inflating lymphocytes. Purification, expanding and cytotoxicity analisys on primary tumor cultures
Tumor inflating lymphocytes. Purification, expanding and cytotoxicity analisys on primary tumor cultures

Yusubalieva G.M., Petrichuk S.V., Krivoshapkin A.L., Kedrova A.G., Ivanov Yu. V., Vinokurov A.G., Kalinkin A.A., Sandjarov A.E., Kim S.V., Ponomarev A.V., Kuptsova D.G., Ischenko Roman, Troitskiy Alexander, Baklaushev V.P.

The effect produced by IL-2 and IL-15 on the proliferation of T cells in vitro in patients diagnosed with breast cancer
The effect produced by IL-2 and IL-15 on the proliferation of T cells in vitro in patients diagnosed with breast cancer

Timofeeva S.V., Filippova S.Yu., Sitkovskaya A.O., Novikova I.A., Kit O.I., Mezentsev S.S., Vashchenko L.N., Kechedzhieva E.E., Dashkova I.R., Ausheva T.V.

GD2-specific car-T cells co-expressing the IL15 membrane form effectively lyse GD2-positive cell targets
GD2-specific car-T cells co-expressing the IL15 membrane form effectively lyse GD2-positive cell targets

Mollaev M.D., Vikhreva P.N., Kibardin A.V., Mayorova V.E., Kholodenko R.V., Kulakovskaya E.A., Pershin D.E., Maschan M.A., Larin S.S.

Adhesive phytoadaptogens geroprotectors in preventive oncology
Adhesive phytoadaptogens geroprotectors in preventive oncology

Bocharova O.A., Karpova R.V., Bocharov E.V., Aksyonov A.A., Chekalina T.L., Chulkova S.V., Ionov N.S., Kazeev I.V., Lyzhenkova M.A., Vershinskaya A.A., Kucheryanu V.G., Kosorukov V.S.

The application of MRNA vectors for CART therapy in vivo
The application of MRNA vectors for CART therapy in vivo

Kulinich T.M., Bozhenko V.K., Ranjit R., Kaprin A.D.

Short address: https://sciup.org/148327389

IDS: 148327389   |   DOI: 10.18137/cardiometry.2023.29.conf.17

Text of the article Dendritic cells and their role in cancer immunotherapy

Issue 29. November 2023 | Cardiometry | 25

References Dendritic cells and their role in cancer immunotherapy

  • Sahin U, Derhovanessian E, Miller M, Kloke BP, Simon P, Lower M, et al. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. Nature (2017) 547(7662):222- 6.
  • Hodi FS, O'Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med (2010) 363(8):711-23.
  • Miller MJ, Foy KC, Kaumaya PT. Cancer immunotherapy: present status, future perspective, and a new paradigm of peptide immunotherapeutics. Discov Med (2013) 15(82):166-76.
  • Ogi, C. & Aruga, A. Immunological monitoring of anticancer vaccines in clinical trials. Oncoimmunology 2, e26012 (2013).
  • Guo C., Manjili M.H., Subjeck J.R., Sarkar D., Fisher P.B., Wang X.Y. Therapeutic cancer vaccines: past, present, and future. Adv Cancer Res. 2013;119:421-75.